ABPI welcomes ambitious NHS vaccination strategy

NHS England has today published its vaccination strategy, setting out how it will increase national uptake of vaccination to protect people against a range of diseases.

In response, Dr Amit Aggarwal, ABPI Director of Medical Affairs said: “We support this comprehensive, ambitious, and thoughtful strategy, which will boost current arrangements and help improve everyone’s health.

“We know from the pandemic that a convenient ‘front door’ for vaccination is crucial, so it is right to focus on locally tailored action by multi-disciplinary teams. Using the opportunity of vaccination to offer a wider set of prevention services is also an important step forward. Too often, communities at the highest risk of vaccine-preventable diseases also have the lowest uptake of vaccines and the worst health outcomes.

“This plan is the right way forward. It will make it easier for people to be protected against disease, and help ensure no one is left behind on vaccination.” 

  • Vaccines

Last modified: 03 March 2024

Last reviewed: 03 March 2024

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.